Public medicine directory

Antineoplastic and Immunomodulating Agents

Browse public medicine summaries, manufacturers, and approval information for Antineoplastic and Immunomodulating Agents.

1653 medicinesPage 48 of 138

After reconstitution, each vial contains 1 ml with 5 mg of monoclonal antibody

Anti-Human T-Lymphocyte CD3 Murine Monoclonal Antibody for Injection (Wuhan Institute of Biological Products)

Anti-human T-lymphocyte CD3 Mouse Monoclonal Antibody for Injection

A public medicine summary is being prepared.

125 mg (10 mL)/bottle

Cadonilimab Injection

A public medicine summary is being prepared.

200 mg/vial.

Camrelizumab for Injection

A public medicine summary is being prepared.

500 mg/50 mL；100 mg/10 mL。